Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

Details for Australian Patent Application No. 2010247761 (hide)

Owner Berg Biosystems, LLC

Inventors Narain, Niven Rajin; McCook, John Patrick; Sarangarajan, Rangaprasad

Agent FB Rice

Pub. Number AU-A-2010247761

PCT Pub. Number WO2010/132440

Priority 61/177,246 11.05.09 US; 61/177,243 11.05.09 US; 61/177,245 11.05.09 US; 61/177,244 11.05.09 US; 61/177,241 11.05.09 US

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/132440 Priority application(s): WO2010/132440

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247763-7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-( 3,4-dichlorophenyl)-1,2,3,4tetrahydroisoquinoline and use thereof

2010247755-Methods for treatment of disease using an epimetabolic shifter (Coenzyme Q10)